Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.

@article{Dematteis2017RecommendationsFB,
  title={Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.},
  author={Maurice Dematteis and Marc Auriacombe and Oscar D'Agnone and Lorenzo Somaini and N{\'e}stor Szerman and Richard Littlewood and Farrukh Alam and Hannu Alho and Amine Benyamina and Julio Bobes and Jean Pierre Daulouede and Claudio Leonardi and Icro Maremmani and Marta Torrens and Stephan Walcher and Michael Soyka},
  journal={Expert opinion on pharmacotherapy},
  year={2017},
  volume={18 18},
  pages={
          1987-1999
        }
}
INTRODUCTION Management of patients with opioid use disorder (OUD) commonly includes opioid agonist therapy (OAT) as a part of an integrated treatment plan. These interventions are associated with proven benefits to the individual and society. Areas covered: The use of methadone and buprenorphine within an integrated treatment plan in the management of patients with OUD: this work provides consensus recommendation on pharmacotherapy in OUD to assist clinicians with practical decision making in… CONTINUE READING
4
Twitter Mentions

Tables and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 87 REFERENCES

National Guidelines for Medication-Assisted Treatment of Opioid Dependence

L Gowing, R Ali, A Dunlop, M Farrell, N. Lintzeris
  • 2014
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…